SEM vs TMO · P/E 15, rev $1.31B vs P/E 24, rev $44.56B
Select Medical Holdings (SEM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Select Medical Holdings (SEM) is a medical care facilities company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported SEM revenue for 2024-12-31 was $1.31B. Net income was $3.8M. Revenue was up 3.2% from 2024-09-30 to 2024-12-31. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
SEM currently screens at market cap $2.05B and trailing P/E 15.5. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the SEM and TMO stock pages for the full models.
Not investment advice.